— Know what they know.
Not Investment Advice

CMRX NASDAQ

Chimerix, Inc.
1W: +0.2% 1M: +0.8% 3M: +140.6% 1Y: +844.7% 3Y: +82.1% 5Y: +454.6%
$8.54
Last traded 2025-04-21 — delisted
NASDAQ · Healthcare · Biotechnology · $801.1M mcap · 80M float · 5.30% daily turnover · Short 39% of daily vol

Balance Sheet Trends

Total Assets
$146M -31.4% ▼
5Y CAGR: +4.1%
Total Liabilities
$24M +23.2% ▲
5Y CAGR: +20.9%
Shareholders Equity
$122M -37.0% ▼
5Y CAGR: +2.0%
Cash & Investments
$31M -83.0% ▼
5Y CAGR: -22.8%
Total Debt
$458K -64.8% ▼
5Y CAGR: +18.5%
Net Debt
-$31M -16.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$47M$15M$26M$28M$31M
Short-Term Investments$32M$73M$191M$155M$0
Cash & ST Investments$79M$88M$217M$183M$31M
Net Receivables$340K$348K$1M$1M$812K
Inventory$0$3M$0$0-$2M
Other Current Assets$2M$5M$10M$3M$105M
Total Current Assets$82M$96M$228M$189M$136M
Property, Plant & Equip.$3M$3M$2M$2M$1M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$2M$49M$22M$8M
Other Non-Current Assets$26K$56K$386K$301K$214K
Total Non-Current Assets$3M$5M$51M$24M$10M
Total Assets$85M$101M$279M$213M$146M
— Liabilities —
Accounts Payable$1M$3M$3M$3M$4M
Short-Term Debt$0$14M$0$0$0
Deferred Revenue$0$0-$773K$0$0
Other Current Liabilities$4M$5M$11M$5M$20M
Total Current Liabilities$9M$30M$20M$18M$24M
Long-Term Debt$0$0$250K$125K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$3M$2M$2M$1M$458K
Total Liabilities$11M$32M$22M$20M$24M
— Equity —
Common Stock$63K$87K$88K$89K$92K
Retained Earnings-$712M-$886M-$713M-$796M-$884M
Accumulated OCI$0-$21K-$337K$7K$0
Total Stockholders Equity$73M$68M$257M$193M$122M
Total Liabilities & Equity$85M$101M$279M$213M$146M
— Key Metrics —
Total Debt$3M$16M$2M$1M$458K
Net Debt-$44M$995K-$24M-$26M-$31M
Total Investments$32M$75M$240M$177M$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms